Omalizumab in patients with severe asthma: the XCLUSIVE study
C Schumann, C Kropf, T Wibmer… - The clinical …, 2012 - Wiley Online Library
Abstract Background and Aims: Although the efficacy and safety of omalizumab (OMA) in
uncontrolled severe allergic asthma has been demonstrated in several randomised …
uncontrolled severe allergic asthma has been demonstrated in several randomised …
[引用][C] Omalizumab in patients with severe asthma: the XCLUSIVE study
C Schumann, C Kropf, T Wibmer, S Ruediger… - 2012 - oparu.uni-ulm.de
Omalizumab in patients with severe asthma: the XCLUSIVE study
C Schumann, C Kropf, T Wibmer… - The clinical …, 2012 - pubmed.ncbi.nlm.nih.gov
Background and aims Although the efficacy and safety of omalizumab (OMA) in uncontrolled
severe allergic asthma has been demonstrated in several randomised controlled trials …
severe allergic asthma has been demonstrated in several randomised controlled trials …
Omalizumab in patients with severe asthma: the XCLUSIVE study.
C Schumann, C Kropf, T Wibmer, S Rüdiger… - The Clinical …, 2011 - europepmc.org
Methods One hundred ninety-five asthmatic patients initiated on anti-Immunoglobulin E (IgE)
IgE treatment were followed-up for 6 months. Forced expiratory volume in 1 s (FEV (1)) …
IgE treatment were followed-up for 6 months. Forced expiratory volume in 1 s (FEV (1)) …
Omalizumab in patients with severe asthma: the XCLUSIVE study
C Schumann, C Kropf, T Wibmer, S Rüdiger… - The Clinical Respiratory …, 2012 - infona.pl
Background and Aims: Although the efficacy and safety of omalizumab (OMA) in
uncontrolled severe allergic asthma has been demonstrated in several randomised …
uncontrolled severe allergic asthma has been demonstrated in several randomised …
Omalizumab in patients with severe asthma: the XCLUSIVE study.
C Schumann, C Kropf, T Wibmer… - Clinical Respiratory …, 2012 - search.ebscohost.com
Abstract Background and Aims: Although the efficacy and safety of omalizumab (OMA) in
uncontrolled severe allergic asthma has been demonstrated in several randomised …
uncontrolled severe allergic asthma has been demonstrated in several randomised …
[PDF][PDF] Omalizumab in patients with severe asthma: the XCLUSIVE studycrj_263 215.. 227
C Schumann, C Kropf, T Wibmer, S Rüdiger… - 2011 - pantherics.com
Abstract Background and Aims: Although the efficacy and safety of omalizumab (OMA) in
uncontrolled severe allergic asthma has been demonstrated in several randomised …
uncontrolled severe allergic asthma has been demonstrated in several randomised …
[引用][C] Omalizumab in patients with severe asthma: the XCLUSIVE study
C Schumann, C Kropf, T Wibmer… - Clinical Respiratory …, 2012 - oparu.uni-ulm.de
Omalizumab in patients with severe asthma: the XCLUSIVE study Toggle navigation English
Deutsch Deutsch English Deutsch Einloggen Toggle navigation Dokumentanzeige Startseite …
Deutsch Deutsch English Deutsch Einloggen Toggle navigation Dokumentanzeige Startseite …